WO2010046929A3 - Novel polymorphic forms of temazepam and processes for preparing the same - Google Patents
Novel polymorphic forms of temazepam and processes for preparing the same Download PDFInfo
- Publication number
- WO2010046929A3 WO2010046929A3 PCT/IN2009/000589 IN2009000589W WO2010046929A3 WO 2010046929 A3 WO2010046929 A3 WO 2010046929A3 IN 2009000589 W IN2009000589 W IN 2009000589W WO 2010046929 A3 WO2010046929 A3 WO 2010046929A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymorphic forms
- temazepam
- processes
- preparing
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed herein are novel crystalline polymorphic forms Form I, Form II, Form III, Form IV, Form V, Form VI, Form VII, Form VIII, Form IX, Form X and amorphous form of temazepam characterized by X-ray powder diffraction patterns, DSC, TGA and IR. In addition, the invention describes processes for the preparation of the various polymorphic forms.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2554CH2008 | 2008-10-17 | ||
IN2554/CHE/2008 | 2008-10-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010046929A2 WO2010046929A2 (en) | 2010-04-29 |
WO2010046929A3 true WO2010046929A3 (en) | 2011-01-27 |
Family
ID=42119786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2009/000589 WO2010046929A2 (en) | 2008-10-17 | 2009-10-16 | Novel polymorphic forms of temazepam and processes for preparing the same |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010046929A2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3296249A (en) * | 1963-06-04 | 1967-01-03 | American Home Prod | 5-monocyclic aryl-1, 3-dihydro-2h-1, 4-benzodiazepin-2-ones |
US4412952A (en) * | 1982-04-30 | 1983-11-01 | Sandoz, Inc. | Process for 3-hydroxy benzodiazepinones |
-
2009
- 2009-10-16 WO PCT/IN2009/000589 patent/WO2010046929A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3296249A (en) * | 1963-06-04 | 1967-01-03 | American Home Prod | 5-monocyclic aryl-1, 3-dihydro-2h-1, 4-benzodiazepin-2-ones |
US4412952A (en) * | 1982-04-30 | 1983-11-01 | Sandoz, Inc. | Process for 3-hydroxy benzodiazepinones |
Also Published As
Publication number | Publication date |
---|---|
WO2010046929A2 (en) | 2010-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008068625A3 (en) | Processes for preparing cinacalcet hydrochloride and polymorphic forms thereof | |
WO2009002427A3 (en) | Methods of synthesizing cinacalcet and salts thereof | |
NZ629684A (en) | Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one | |
IL220049A0 (en) | Post-operative adjustment tool, minimally invasive attachment apparatus, and adjustable tricuspid ring | |
WO2009025876A3 (en) | Crystalline forms of erlotinib hcl and formulations thereof | |
WO2007076245A3 (en) | Novel hydrogen sulfate salt | |
HK1201822A1 (en) | Process for the preparation of 5,6-dihydro-1h-pyridin-2-one compounds 56--1h--2- | |
WO2008070072A3 (en) | Carvedilol forms, compositions, and methods of preparation thereof | |
WO2008021342A3 (en) | Amorphous and crystalline forms of 9-hydroxy-risperidone ( paliperidone ) | |
WO2007141593A3 (en) | Process for the preparation of metoprolol and its salts | |
WO2011024192A3 (en) | Novel polymorphs of raltegravir | |
WO2012085927A3 (en) | Tadalafil compositions | |
WO2009151899A3 (en) | Preparation of imatinib mesylate | |
IL195757A0 (en) | Processes for preparing intermediate compounds useful for the preparation of cinacalcet | |
WO2009120746A3 (en) | Crystalline forms of sitagliptin phosphate | |
WO2010070677A3 (en) | A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof | |
WO2012035544A3 (en) | A novel polymorphic form of rifaximin and process for its preparation | |
WO2010008735A3 (en) | Solid states of o-desmethylvenlaf axine salts | |
WO2007119120A3 (en) | Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation | |
WO2007098273A3 (en) | Novel crystalline forms of armodafinil and preparation thereof | |
WO2009037538A3 (en) | Process for the preparation of lamivudine form i | |
WO2009065872A3 (en) | Processes for the synthesis of varenicline l-tartrate | |
WO2010027848A3 (en) | Forms of lapatinib compounds and processes for the preparation thereof | |
WO2009025792A3 (en) | Crystalline forms cinacalcet fumarate and cinacalcet succinate and processes for preparation thereof | |
WO2008035360A3 (en) | Novel crystalline forms of candesartan cilexetil, candesartan, tritylated candesartan and tritylated candesartan cilexetil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09821702 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09821702 Country of ref document: EP Kind code of ref document: A2 |